Used in pharmaceutical research as a potent and selective inhibitor of specific kinase enzymes involved in cancer cell signaling pathways. It shows promise in targeting tumor growth and proliferation, particularly in solid tumors, by blocking abnormal protein activity that drives uncontrolled cell division. Its structure allows for high binding affinity and improved metabolic stability, making it a candidate for oral anticancer therapies. Currently investigated in preclinical studies for efficacy, pharmacokinetics, and safety profiling.